Join the club for FREE to access the whole archive and other member benefits.

Regeneron Pharmaceuticals

Biotechnology company

Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Eastview, near Tarrytown, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, it branched out into the study of both cytokine and tyrosine kinase receptors.

Visit website:




People at Regeneron Pharmaceuticals

Tea Shavlakadze

Director of Aging/Age-Relateddisorders at Regeneron Pharmaceuticals

George Yancopoulos

Scientific Founder, President and Chief Scientific Officer at Regeneron

David Glass

Vice President, Research, Aging/Age-Related Disorders, at Regeneron Pharmaceuticals

Regeneron Pharmaceuticals News

Unity Biotechnology's diabetic macular edema senolytic treatment shows promise at 48-week endpoint

FierceBiotech - 24-Apr-2023

Corporate shift towards ophthalmology puts senolytics head-to-head against existing treatments


New CRISPR gene-editing drug for a rare protein-misfolding disorder

pharmaphorum - 28-Jun-2021

Phase 1 trial reports, single dose of the drug cuts protein levels by 87% in ATTR amyloidosis


Adicet merges with resTorbio for CAR T-cell therapy pipeline funding

FierceBiotech - 30-Apr-2020

The deal moves company forward to initiating phase 1 trials in non-Hodgkin lymphoma next year


How DNA sequencing is transforming the hunt for new drugs

Reuters - 13-May-2015

Pharmaceuticals companies analysings hundreds of thousands of DNA samples to identify new gene ta...